Potential role of the new specific COX-2 inhibitors in dermatologic surgery.
Weisberg
N K
NK
Weill Cornell University Medical Center, New York, New York 10021, USA.
Becker
D
D
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010149:Postoperative Pain / Q000188:drug therapy* / Q000517:prevention & control; D011300:Preoperative Care; D011720:Pyrazoles; D012871:Skin Diseases / Q000601:surgery*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib